p-Tolualdehyde structure
|
Common Name | p-Tolualdehyde | ||
|---|---|---|---|---|
| CAS Number | 104-87-0 | Molecular Weight | 120.148 | |
| Density | 1.015 | Boiling Point | 204-205 ºC | |
| Molecular Formula | C8H8O | Melting Point | -6 °C | |
| MSDS | Chinese USA | Flash Point | 80 ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of p-Tolualdehydep-Tolualdehyde is an endogenous metabolite. |
| Name | p-tolualdehyde |
|---|---|
| Synonym | More Synonyms |
| Description | p-Tolualdehyde is an endogenous metabolite. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Density | 1.015 |
|---|---|
| Boiling Point | 204-205 ºC |
| Melting Point | -6 °C |
| Molecular Formula | C8H8O |
| Molecular Weight | 120.148 |
| Flash Point | 80 ºC |
| Exact Mass | 120.057518 |
| PSA | 17.07000 |
| LogP | 2.10 |
| Vapour Pressure | 0.3±0.4 mmHg at 25°C |
| Index of Refraction | 1.558 |
| InChIKey | FXLOVSHXALFLKQ-UHFFFAOYSA-N |
| SMILES | Cc1ccc(C=O)cc1 |
| Water Solubility | 0.25 g/L (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22;R36/38 |
| Safety Phrases | S26-S36-S37/39 |
| RIDADR | NA 1993 / PGIII |
| WGK Germany | 1 |
| RTECS | CU7034500 |
| Packaging Group | I; II; III |
| HS Code | 2912299000 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2912299000 |
|---|---|
| Summary | 2912299000. other cyclic aldehydes without other oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
|
Synthesis, luminescence, and electrochemical studies of a new series of octanuclear ruthenium(II) complexes of tolylterpyridine appended calixresorcarenes.
Dalton Trans. 44 , 14813-22, (2015) A new series of octanuclear Ru(ii) complexes of tolylterpyridine appended calixresorcarenes [{Ru(ttpy)}8()](PF6)16 (), [{Ru(ttpy)}8()](PF6)16 (), and [{Ru(ttpy)}8()](PF6)16 () [ = 2,8,14,20-tetraethyl... |
|
|
Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
J. Med. Chem. 48 , 440-9, (2005) The purpose of this study was to develop screening and in silico modeling methods to obtain accurate information on the active center of CYP2A6, a nicotine oxidizing enzyme. The inhibitory potencies o... |
|
|
Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes.
Bioorg. Med. Chem. 15 , 4775-99, (2007) A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compou... |
| p-Tolualdehyde |
| 4-Toluylaldehyde |
| para-Methylbenzaldehyde |
| para-Tolualdehyde |
| 4-Methyl-Benzaldehyde |
| p-Formyltoluene |
| 4-Methylbenzaldehyde |
| p-Tolylaldehyde |
| p-Toluylaldehyde |
| para-Toluyl aldehyde |
| p-Methylbenzaldehyde |
| 4-Tolualdehyde |
| MFCD00006954 |
| EINECS 203-246-9 |
| p-Methyl benzaldehyde |